4,6-Dimethylfuro[2,3-d]pyrimidin-2-amine, 95.0%, 5g

Methyl 3,5-diamino-6-chloropyrazine-2-carboxylate, 98.0%, 5g

8-FLUOROISOQUINOLIN-4-AMINE, 95.0%, 1g

tert-butyl (3S)-3-({[(benzyloxy)carbonyl]amino}methyl)pyrrolidine-1-carboxylate, 97.0%, 10g

4-(4-Chloro-3-(trifluoromethyl)phenyl)piperidin-4-ol, 95.0%, 5g

Solution d'hydroxyde de sodium 50 %, extra pure, 10 l, emballage plastique.

1-(4-(Benzyloxy)-6-chloro-2-methoxypyridin-3-yl)ethan-1-one, 97%, 100mg

3-(5-Chloro-1H-indol-3-yl)propan-1-amine, 97.0%, 1g

2-(5-methoxy-1H-indol-3-yl)-2-(4-methoxyphenyl)ethanamine, 50mg

tert-Butyl 5-aminoisoindoline-2-carboxylate, 95.0%, 10g

2,5-Dibromo-3,6-dihydroxycyclohexa-2,5-diene-1,4-dione, 98%, 25g

6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline, 95.0%, 250mg

(3R)-3-Methylpiperidin-3-ol hydrochloride, 98%, 250mg